Main Page
About US
Director Message
No. Decision and Establashment Date
vision & mission
Our objectives
Our achievements
Organization Chart
Administration
Executive Board
Administrative Board
Scientific Advisor Committee
Postgraduate Committee
Ethical Committee
Elite Student Program Committee
Administrative Unit
Secretary Unit
Employment Unit
Ordering and Purchasing Unit
IT Unit
Financial Unit
Public Relations and Marketing Unit
Transportation Unit
Researchers
Senior Staff
Research Leaders
Research Staff
Technical Staff Labs
Research Programs
About Research Programs
Biobanking & Biospecimen Research Program
Cancer Genomic Research Program
Functional & Developmental Genomics Research Progr
Genomic Screening Research Program
Neurogenetic Research Program
Pharmacogenomics Research Program
Tissue Culture & Regenerative Medicine Research
Research Service Units
About Research Service Units
Biobanking Unit
Bioimaging Unit
Bioinformatics Unit
Biomedical Engineering Unit
Diagnostic & Genomic Medicine Unit (DGMU)
Cytogenetic Service Unit
Molecular Service Unit
Flowcytometry Unit
Genetic Counselling Unit
High-Throughput Sequencing Unit
Histopathology Unit
Microarray (Affymetrix) Unit
Microarray (Agilent) Unit
Pharmacogenomics & Drug Discovery Unit
Preimplantation Genetic Diagnosis Unit
Proteomics and Metabolomics Unit
Quantitative Genotyping Unit
Teratogenecity & Toxicity Unit
Tissue Culture Unit
Education & Outreach Program
About Education & Outreach Program
Master of Science Program
About the Program
Master Students
Doctor of Philosophy Program
About the Program
Ph.D. Students
Training Program
About Program
Specialized Training Program in Clinical Cyto.
Public Awareness Program
Collaborations
About Collaborations
National Level Collaborations
International Level Collaborations
Quality Management Program
About Quality Management Program
QMP Outline
QMP Aims and Function
Publications
CEGMR Publication List
Submit Publication Permission Request
CEGMR Booklets
CEGMR Newsletter
CEGMR Workshops
Conferences and Seminars
CEGMR Training Programs
Conferences & Workshops
Conferences
Workshops
Seminars and Training Courses
Parteners
Academic Parteners
National
International
Commercial Parteners
National
International
Related Links
Government
Journals
Non-Governmental Organizations
International Organizations
Medical Dictionaries
Search Engines for Researchers
PhotoAlbum
Files
Contact Us
Center map
Site Map
Latest News
Our Events
CEGMR Research
Research
Application for Employment
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Center of Excellence In Genomic Medicine Research
Document Details
Document Type
:
Article In Journal
Document Title
:
Utilization of amplicon-based targeted sequencing panel for the massively parallel sequencing of sporadic hearing impairment patients from Saudi Arabia
Utilization of amplicon-based targeted sequencing panel for the massively parallel sequencing of sporadic hearing impairment patients from Saudi Arabia
Document Language
:
English
Abstract
:
Background: Hearing Impairment (HI) can have genetic or environmental causes and in some cases, an interplay of both. Genetic causes are difficult to determine as mutations in more than 90 genes have been shown recently to be responsible for HI. Providing a genetic diagnostic test for HI is therefore a challenge especially for ethnic groups where GJB2 mutations are shown to be rare. Results: Here we show the design and implementation of an amplicon-based targeted sequencing panel that allows the simultaneous sequencing of 87 HI genes. Mutations identified included known pathogenic mutations and novel variants with unknown significance. The diagnostic rate of this panel is 28 % when only pathogenic variants were reported. However, an additional 28 % harbored recurrent combinations of novel or rare single nucleotide variants in the OTOF or PCDH15 genes. Such combinations were not identified in healthy individuals. Conclusions: Targeted sequencing approach is a very useful strategy for the identification of mutations affecting the HI genes because of its relatively fast turn-around time and cost effectiveness compared to whole-exome sequencing. Further novel or rare variants could be identified by implementing a large-scale screening of HI using our panel which will eventual lead to a higher diagnostic rate.
ISSN
:
1471-2350
Journal Name
:
BMC medical genetics
Volume
:
17
Issue Number
:
1
Publishing Year
:
1437 AH
2016 AD
Article Type
:
Article
Added Date
:
Tuesday, July 18, 2017
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
Ashraf Dallol
Dallol, Ashraf
Researcher
Doctorate
Kamal Daghistani
Daghistani, Kamal
Researcher
Doctorate
Aisha Elaimi
Elaimi, Aisha
Researcher
Doctorate
Wissam A Al-Wazani
Al-Wazani, Wissam A
Researcher
Doctorate
Afaf Bamanie
Bamanie, Afaf
Researcher
Doctorate
Malek Safiah
Safiah, Malek
Researcher
Doctorate
Samira Sagaty
Sagaty, Samira
Researcher
Doctorate
Layla Taha
Taha, Layla
Researcher
Doctorate
Rawabi Zahed
Zahed, Rawabi
Researcher
Doctorate
Osama Bajouh
Bajouh, Osama
Researcher
Doctorate
Adeel Gulzar Chaudhary
Chaudhary, Adeel Gulzar
Researcher
Doctorate
Mamdooh Abdullah Gari
Gari, Mamdooh Abdullah
Researcher
Doctorate
Rola Turki
Turki, Rola
Researcher
Doctorate
Mohammed Hussein Al-Qahtani
Al-Qahtani, Mohammed Hussein
Researcher
Doctorate
Adel Mohammed Abuzenadah
Abuzenadah, Adel Mohammed
Researcher
Doctorate
Files
File Name
Type
Description
42097.pdf
pdf
Back To Researches Page